Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > FSD Shareholders

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Jun 01, 2021 4:58pm

34 Views

Post# 33306345

RE:RE:RE:FSD Shareholders

No it eon't because the motion that would have tranformed the Class A share structure to allow Class B investors to have an actual say in the direction of the company was voted down by AD and the Concerned Shareholders....I wonder why that ios....mabe because they would actually become accountable to investors.....